Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years

08 Apr 20264 min read0 viewsINTERVENTIONAL Trial

GIST

RECRUITING · INTERVENTIONAL · PREVENTION study · Chlamydia Trachomatis Immunization · Phase 1 · Enrollment 1560 · Sponsor: Sanofi

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Infectious Disease on 08 Apr 2026. The item focuses on Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years. Open the detail page to review the full original feed content.